Fate Therapeutics Inc. buy Piper Sandler
Start price
17.06.24
/
50%
€3.65
Target price
17.06.25
€5.60
Performance (%)
-71.37%
End price
18.06.25
€1.05
Summary
This prediction ended on 18.06.25 with a price of €1.05. Massive losses of -71.37% were the result for the BUY prediction by Piper_Sandler. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fate Therapeutics Inc. | -3.464% | -3.464% | -44.103% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Piper_Sandler for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $6.00 price target on the stock, up previously from $4.00.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten